Streamline Verify considers itself fortunate to be running without incident throughout the COVID-19 pandemic due to the nature of its business. However, they have seen firsthand many of their own clients who are all healthcare organizations, on the front lines...
SCCE Covid-19 Survey shows Decreased Compliance Budgets
July 28, 2020
The Society of Corporate Compliance and Ethics and the Health Care Compliance Association have recently released a new report on “Compliance and the COVID-19 Pandemic”. This blog summarizes the main findings from this study of 343 compliance and ethics professionals’...
New Antibody Testing Follow-on Study
July 16, 2020
On the heels of the NIH-supported Expanded Access Program (EAP) for Convalescent Plasma, a secondary antibody testing modality has been developed as part of the Antibody Everybody initiative powered by Streamline Verify. Researchers are eagerly seeking data to know and...
A MESSAGE FROM OUR CEO
July 13, 2020
Dear Valued Partners,I hope this letter finds you and your loved ones safe and in good health during this relentless pandemic.COVID-19 has given our team an even deeper appreciation and reverence for healthcare compliance. This challenging time has inspired us...
Streamline Verify Helps Launch Development of COVID-19 Data Research
July 9, 2020
During the SARS and Ebola viral outbreaks, minimal effective medication existed, and an encouraging medical treatment technique called Convalescent Plasma was deployed showing clinical promise. The treatment derived from a patient’s blood who had the disease and recovered. This approach...
COVID-19 Toolkit: Liability & Licensure Protections & On-Site Volunteer Resources
May 15, 2020
The U.S. Department of Health and Human Services (HHS) Assistant Secretary for Preparedness and Response (ASPR) created a new toolkit under their Technical Resources, Assistance Center, and Information Exchange (TRACIE) unit. This toolkit was created to meet the information and...
FDA’s Warning Letter Database now screens for COVID-19 Violations
May 11, 2020
A public facing FDA Warning Letter Database exists regarding manufacturers that commit violations of U.S. Food and Drug Administration (FDA) regulations. Recently, this database began flagging organizations for COVID-19 related violations. Specifically, this database captures warning letters that the FDA...
Did you notice these changes to OIG’s searchable database?
December 6, 2019
Having an individual’s Social Security Number (SSN) or the entity’s Employee Identification Number (EIN) can assist in your exclusion screening efforts. A common method to resolve potential matches found on the LEIE, is by entering in their SSN or EIN...
